• December 3, 2020  

    Opdivo Approved in Europe as Second-line Therapy for Advanced Esophageal Cancer Bookmark

    George Lundberg, MD

    Immuno-Oncology News reports on the European Commission’s approval of the drug nivolumab (Opdivo) for some patients with advanced esophageal cancer.

    .

  • December 3, 2020  

    Olaparib Granted Positive EU Opinion for BRCA1/2+ Advanced Prostate Cancer Bookmark

    George Lundberg, MD

    A news story published by OncLive reports that the European Union’s Committee for Medicinal Products for Human Use recently approved the drug olaparib for treating patients with a subset of advanced castrate-resistant prostate cancers that have BRCA1/2 mutations.

    .

  • November 24, 2020  

    Two New Treatments Approved For Advanced Prostate Cancer Bookmark

    George Lundberg, MD

    A story published by the Prostate Cancer Foundation outlines two new treatment options approved by the U.S. Food and Drug Administration (FDA) this year. The two medications, rucaparib and olaparib, each target specific mutations that may be found in a patient’s tumor, and each was approved for a specific type of prostate cancer.

    .

  • November 24, 2020  

    Cancer Vaccine UV1 Plus Keytruda Shows Safety, Early Efficacy in Advanced Melanoma Trial Bookmark

    George Lundberg, MD

    A story from Immuno-Oncology News covers new results from a phase 1 clinical trial that indicate promising safety and early efficacy of a treatment that combines the drug Keytruda and an experimental cancer vaccine for people with advanced melanoma.

    .

  • November 24, 2020  

    Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib Bookmark

    George Lundberg, MD

    This scientific research paper published in JAMA Oncology reports results from a clinical trial in which the drugs nivolumab and ipilimumab showed promising safety and efficacy for people with advanced liver cancer who had previously received the drug sorafenib.

    .

  • November 6, 2020  

    What’s New in Treatments that Target the MAPK Pathway in Cancer?

    Emma Shtivelman, PhD

    If you are learning about treatment options for your or your loved one’s cancer, you may have heard of the MAPK pathway. This biological feature of human cells has become an important target of numerous drugs to treat cancer. Read on to learn more about the MAPK pathway and the current status of treatments that target it. What is the MAPK pathway? The mitogen-activated… Read more »

  • October 28, 2020  

    Pancreatic Cancer: Why Diet Is Important

    H. Sofia Pereira, PhD

    Pancreatic cancer and nutrition are closely intertwined. Research has shown that diet can help many patients manage the loss of appetite and weight loss that often accompany pancreatic cancer, and good nutrition is linked to better treatment outcomes. Intriguingly, mounting evidence also suggests that specific diets may directly affect the underlying biology of pancreatic tumors and improve the success of pancreatic cancer treatment. Read… Read more »

  • October 26, 2020  

    How an Expert Would Manage His Own Stage 4 Pancreatic Cancer

    With: John H. Strickler, MD

    When confronted with a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Cancer Commons Expert Physician Advisor John Strickler, MD, how he would handle his own diagnosis of metastatic pancreatic cancer. Dr. Strickler is Associate Professor of Medicine in the Division of Medical Oncology at Duke University and Co-Leader of… Read more »

  • October 22, 2020  

    ESMO 2019: Immunotherapy in Cervical and Endometrial Cancers Bookmark

    George Lundberg, MD

    Article from The ASCO Post curated by Contributing Editor George Lundberg, MD, who notes: 

    Recent clinical trial results show that immunotherapy—a type of treatment that boosts the immune system to fight cancer—provided long-lasting, improved outcomes for patients with advanced cervical or endometrial cancer. These are important findings for difficult-to-treat cancers.

    .

  • October 22, 2020  

    Malignant Melanoma Treatment & Management Bookmark

    George Lundberg, MD

    Overview from Medscape curated by Contributing Editor George Lundberg, MD, who notes:

    The dramatic array of treatment options now available for this serious disease is nicely summarized in this review. (Free registration required, written with a physician audience in mind.)

    .